LianBio ADR exotic insider transaction detected

LIANDelisted Stock  USD 2.18  0.05  2.24%   
About 61% of LianBio ADR's investor base is looking to short. The analysis of current outlook of investing in LianBio ADR suggests that many traders are alarmed regarding LianBio ADR's prospects. LianBio ADR's investing sentiment overview a quick insight into current market opportunities from investing in LianBio ADR. Many technical investors use LianBio ADR stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Filed transaction by Lianbio director. Unconventional Insider trading

Read at macroaxis.com
LianBio insider trading alert for general transaction of series seed preferred shares by Perceptive Advisors Llc, the corporate stakeholder, on 1st of June 2023. This event was filed by Lianbio with SEC on 2021-10-29. Initial filing of beneficial ownership - SEC Form 3

LianBio ADR Fundamental Analysis

We analyze LianBio ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LianBio ADR using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LianBio ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Insiders

Shares Owned By Insiders Comparative Analysis

LianBio ADR is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

LianBio ADR Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with LianBio ADR stock to make a market-neutral strategy. Peer analysis of LianBio ADR could also be used in its relative valuation, which is a method of valuing LianBio ADR by comparing valuation metrics with similar companies.

Peers

LianBio ADR Related Equities

TILInstil Bio   2.52   
0%
50.0%
SNSESensei Biotherapeutics   2.33   
0%
46.0%
TERNTerns Pharmaceuticals   2.12   
0%
42.0%
INZYInozyme Pharma   1.68   
0%
33.0%
LRMRLarimar Therapeutics   0.98   
0%
19.0%
ASMBAssembly Biosciences   0.20   
0%
4.0%
ELDNEledon Pharmaceuticals   0.45   
9.0%
0%
DAWNDay One   0.47   
9.0%
0%
HOOKHookipa Pharma   0.47   
9.0%
0%
NUVBNuvation Bio   0.76   
15.0%
0%
NXTCNextCure   0.92   
18.0%
0%
FENCFennec Pharmaceuticals   0.98   
19.0%
0%
ABOSAcumen Pharmaceuticals   1.93   
38.0%
0%
ACHLAchilles Therapeutics   2.94   
58.0%
0%
VRCAVerrica Pharmaceuticals   5.00   
100.0%
0%
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Consideration for investing in LianBio Stock

If you are still planning to invest in LianBio ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LianBio ADR's history and understand the potential risks before investing.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Stocks Directory
Find actively traded stocks across global markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Valuation
Check real value of public entities based on technical and fundamental data